XJPX4120
Market cap19mUSD
Dec 30, Last price
2,290.00JPY
1D
6.56%
1Q
9.05%
Jan 2017
65.94%
Name
Sugai Chemical Industry Co Ltd
Chart & Performance
P/E
6.12
P/S
0.39
EPS
374.39
Div Yield, %
1.94%
Shrs. gr., 5y
-0.94%
Rev. gr., 5y
6.72%
Revenues
7.62b
+7.90%
Net income
489m
-15.52%
CFO
1.19b
+27.75%
Dividend
Mar 28, 20250 JPY/sh
Profile
Sugai Chemical Industry Co., Ltd. manufactures and sells various chemicals in Japan. The company offers pharmaceutical intermediates that are used in manufacturing circulatory systems, respiratory systems, antimicrobial and antiviral, cancer, and central nervous system agents; and active ingredients and intermediates, such as fungicides, insecticides, herbicides, and veterinary pharmaceuticals. It also provides functional chemicals that are used in manufacturing of optical and electronic materials, resins and monomers, cosmetics, and fragrances; dye and pigment intermediaries; and surfactants. The company was formerly known as Sugai Chemical Factory and changed its name to Sugai Chemical Industry Co., Ltd. in 1952. Sugai Chemical Industry Co., Ltd. was founded in 1928 and is headquartered in Wakayama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | |||||||||
Revenues | 7,617,230 7.90% | 7,059,466 13.26% | 6,232,914 3.74% | ||||||
Cost of revenue | 7,106,813 | 5,806,680 | 5,133,643 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 510,417 | 1,252,786 | 1,099,271 | ||||||
NOPBT Margin | 6.70% | 17.75% | 17.64% | ||||||
Operating Taxes | (20,109) | 158,331 | 79,887 | ||||||
Tax Rate | 12.64% | 7.27% | |||||||
NOPAT | 530,526 | 1,094,455 | 1,019,384 | ||||||
Net income | 489,105 -15.52% | 578,931 43.13% | 404,468 27.23% | ||||||
Dividends | (58,147) | (46,570) | (40,902) | ||||||
Dividend yield | 1.47% | 1.57% | 2.01% | ||||||
Proceeds from repurchase of equity | (216) | (248) | (99,833) | ||||||
BB yield | 0.01% | 0.01% | 4.92% | ||||||
| Debt | |||||||||
Debt current | 920,402 | 1,180,595 | 1,530,294 | ||||||
Long-term debt | 825,800 | 870,448 | 1,031,767 | ||||||
Deferred revenue | 418,893 | 395,434 | |||||||
Other long-term liabilities | 436,632 | 1,403 | 1,402 | ||||||
Net debt | (918,472) | (210,521) | (121,094) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 1,190,538 | 931,904 | 1,441,516 | ||||||
CAPEX | (479,000) | (616,027) | (975,032) | ||||||
Cash from investing activities | (495,877) | (658,301) | (948,864) | ||||||
Cash from financing activities | (396,231) | (537,754) | (595,836) | ||||||
FCF | 818,851 | 799,710 | 1,280,773 | ||||||
| Balance | |||||||||
Cash | 731,008 | 431,076 | 693,994 | ||||||
Long term investments | 1,933,666 | 1,830,488 | 1,989,161 | ||||||
Excess cash | 2,283,812 | 1,908,591 | 2,371,509 | ||||||
Stockholders' equity | 5,347,914 | 4,809,349 | 4,423,847 | ||||||
Invested Capital | 7,119,532 | 7,124,150 | 6,835,467 | ||||||
ROIC | 7.45% | 15.68% | 14.59% | ||||||
ROCE | 5.43% | 13.62% | 11.69% | ||||||
| EV | |||||||||
Common stock shares outstanding | 1,306 | 1,309 | 1,366 | ||||||
Price | 3,020.00 33.10% | 2,269.00 52.69% | 1,486.00 -6.42% | ||||||
Market cap | 3,944,120 32.79% | 2,970,121 46.32% | 2,029,876 -6.63% | ||||||
EV | 3,025,648 | 2,759,600 | 1,908,782 | ||||||
EBITDA | 975,139 | 1,713,948 | 1,556,470 | ||||||
EV/EBITDA | 3.10 | 1.61 | 1.23 | ||||||
Interest | 11,088 | 11,301 | 12,583 | ||||||
Interest/NOPBT | 2.17% | 0.90% | 1.14% | ||||||